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1. Introduction 
Various hormonal factors such as catecholamines 
by their ~-adrenergic component, ACTH and glucagon 
increase the rate of lipolysis by increasing adenylate 
cyclase (EC 4.6.1 .I) activity and cyclic AMP levels 
[I]. On the other hand, catecholamines bytheir 
cu-adrenergic component and prostaglandin El (PGEQ 
have been shown to lower stimulated cyclic AMP 
levels and to decrease the tipolysis in hamster fat cells 
[2,3]. Except for a prelimina~ ~a~unication f4], 
inhibition of fat cell adenylate cyclase by catechol- 
amines or PGEi has not been demonstrated in cell- 
free preparations. 
The essential role of guanyl nueleotides inhormonal 
stimulation of adenylate cyclase is well establi~~d 
(reviewed [51). On the other hand, a requirement for 
GTP has been shown for the inhibitory effect of 
cu-adrenergic agonists on platelet adenylate cyclase 
/6] and subsequently also for adenylate cyclase inhi- 
bition by adenosine in rat fat cells [7], by muscarinic 
eholinergic agonists in dog and rabbit myocardium 
[8,9] and by cu-adrenergic agonists and opiates in 
neuroblastoma X glioma hybrid cells [lo]. Guanyl 
nucleotides have been shown to decrease the apparent 
affmity of hormone receptors to various agonists that 
stimulate adenylate cyclase (5,111. Similar effects have 
been described for opiate [ 121 and or-adrenergic [ 131 
receptors, which appear to be involved in hormone- 
induced adenylate cyclase inhibition. In studies on 
these receptors, it has been found that besides guanyl 
nucleotides monov~ent cations can modulate the 
receptor affinity with similar but not identical pat- 
terns 112-151. 
In hamster fat cells, where a-adrenergic receptors 
have been demonstrated [ 161, we have studied the 
influence of the cu-adrenergic component of epineph- 
rine and of PGEr on adenylate cyclase and report 
here that GTP and Nd are required for the inhibi- 
tion of the enzyme by these hormonal factors. 
2. Materials and methods 
These were essentialIy as in [ 171. Male golden ham- 
sters (60-100 g) were fed ad libitum. After decapita- 
tion, epididymal fat pads were removed, and isolated 
fat cells were prepared following the methods in [ 181. 
Usually, 2 g adipose tissue were incubated for S-10 
min at 37°C in 3 ml 130 mM NaCl, 2.7 mM KCl, 
1 mM CaC12,1.2 mM MgCl%, 11 mM glucose, 23.8 mM 
Hepes (pH 7.4) containing 50 mg/ml bovine serum 
albumin and 1.6’7 mgjml collagenase. The isolated, 
washed cells were lysed in a medium ~onta~ing 
2.5 mM MgCl,, 1 mM KHC05, 1 mM ATP, 2 mM 
t~~hydroxymethyl~-am~nometh~e (pH 7.6) and 
the resulting fat ceil ghosts were finally suspended 
in 1 mM KHCOa and frozen in liquid nitrogen, by 
the method in [ 191. 
Adenylate cyclase activity was determined as in 
]17], with usually 0.02 mM [(u-~?]ATP, 10 mM 
MgC12, 1mM 3-isobutyl-I-methylx~thine, 0.1 mM 
CAMP, 5 mM creatine phosphate, 0.4 mg/ml creatine 
kinase and 0.2% bovine serum albumin in 50 mM 
trieth~ol~ine-HCl buffer (pH 7.4) at 2S°C in 0.1 ml 
total vol. Reactions were initiated by the addition of 
hamster fat ceil ghosts (5-20 pg protein) and con- 
ducted for IO min or as indicated. Cyclic AMP formed 
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was isolated as in [ 171. For sodium-free conditions, 
creatine phosphate was used as its ammonium salt, 
which was prepared by ion-exchange chromatography 
on QAE-Sephadex A-25, formate form, and elution 
by ammonium formate. Comparable results to those 
shown in the figures and table were obtained in 22 
separate xperiments in each case. Standard evia- 
tions of triplicate determinations were 6% of the 
means. Protein was determined according to [20], 
using bovine serum albumin as standard. 
3. Results 
In rat fat cells, GTP exerts an in~bito~ effect on 
basal adenylate cyclase activity, with pronounced 
inhibition at <37”C [21]. When adenylate cyclase 
activity was determined in hamster fat cell ghosts at 
25’C, GTP caused a marked reduction of the activity, 
which was most pronounced uring the first 3 min 
~cubat~on (fig. 1). This effect of GTP was half-maxi- 
mal at 4l.l MM and a maximal reduction by -80% 
occurred at lo-30 PM GTP (not shown). NaCl, when 
added at 120 mM, had no effect on cyclic AMP for- 
mation in the absence of GTP, but increased the GTP- 
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Fig. 2. Influence of NaCI on GTP- and GTP plus PGE,-induced 
adenylate cyclase inhibition. The effect of NaCl on adenylate 
cyclase activity was studied in the absence (open squares) 
and presence of GTP (10 FM; fried symbols), which was 
added without (squares) and with PGE, (0.1 HM; triangles). 
Creatine phosphate was used as its ammonium salt. 
reduced activity by -2”fold. The effect of NaCl 
appeared to be immediate and was constant over 
212 min incubation, The activation of the GTP-inhib- 
ited form of the enzyme by NaCl was half-maximal t 
50-100 mM NaCl and maximal at -300 mM (fig. 2). 
NaCl, at higher concentrations, reduced the activity 
as it did in the absence of GTP. 
PGE, (b.Ol-10 PM) had no effect on adenylate 
cyclase activity in the absence of GTP. In the pres- 
ence of GTP (10 PM), PGEt caused only slight inhibi- 
tion, when added in the absence of NaCl, but a strong 
Fig. 1. Effects of GTP and NaQ on adenylate cyclase activ- 
ity. In the absence (open symbols) and presence of GTP 
(30 JLM; filed symbols), cyclic AMP accumulation was 
studied without (squares) and with NaQ (120 mM; triangles), 
which was added at zero time point and at 6 mm as indicated 
by the arrow. 
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inhibitory effect of PGEr (0.1 PM) revealed with 
increasing concentrations of NaCl (see fig. 2). The 
activation of the GTP-inhibited enzyme by NaCl was 
apparently counteracted by PGEr. The PGEr-induced 
inhibition was half-maximal t -10-30 mM NaCl, 
and maximal inhibition by SO-6% occurred at 
100 mM NaCl. Similar findings were obtained with 
epinephrine, which inhibited the enzyme by its 
cr-adrenergic component. 
Figure 3 shows the requirement for GTP besides 
that for NaCl for the inhibition of hamster fat cell 
adenylate cyclase by PGEr and the a-adrenergic com- 
ponent of epinephrine, which was added in combina- 
Fig, 3. Influence of GTP on PGE,- and epinephrineinduced 
adenylate cyclase inhibition. In the presence of NaCl(l20 mM), 
the influence of GTP was studied on adenylate cyclase activ- 
ity without and with PGE, (0.1 MM) or lepinephrine (300 PM). 
Inhibitions (%) caused by PGE, (squares) or epinephrine 
(triangles) are given at the indicated concentrations of GTP. 
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Fig. 4. Time-course of PGE,- and epinephrineinduced adenylate cyclase inhibition. In the presence of GTP (10 MM), the effects of 
PGE, (0.1 MM; left panel) and l-epinephrme (100 MM; right panel) were studied on cyclic AMP accumulation without (open 
symbols) and with NaCl(l20 mM;closed symbols). Squares represent control values and triangles the presence of PGE, or epineph- 
rine, which were added at zero time point and at 6 min as indicated by the arrows. 
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tion with the fl-adrenergic blocking agent, propranolol 
(30pM). Inhibition by either agonist was half-maximal 
at -0.1 FM GTP, and maximal i~ibition by PGEr 
and epinephr~e by 60% and 30%, respectively, 
occurred at 1 I.IM GTP. At higher concentrations 
(<l mM), GTP did not reverse the hormone-induced 
adenylate cyclase inhibition. The inhibitory effects 
of PGEr and epinephrine observed in the presence of 
GTP and NaCl were apparently immediate, indepen- 
dently whether the agents were added with the enzyme 
or 6 min after having started the assay reaction (fig. 4). 
The effects were also independent of the ATP con- 
centration used (GO.2 mM; not shown). The enzyme 
inhibition by epinephrine was completely reversed 
by the ar-adrenergic blocking agent, phentol~e 
(30 PM), which finding supports the assumption that 
cw-adrenergic re eptors are involved in this catechol- 
amine effect. 
To determine the specificity of NaCl and to find 
out whether the effects of NaCl were primarily due 
to the cation or the associated anion or were due to 
the increased osmolarity of the assay medium, we have 
evaluated the influences of a variety of monovalent 
cations as their respective chloride salts and have 
compared the effects of Na2S04, NaC!l and sucrose on 
adenylate cyclase activity in the absence and presence 
of PGEi and ep~eph~e (table 1). Na2S04 and LiCl, 
similar to NaCl, increased enzyme activity in the 
presence of GTP by -2-fold. However, only with 
NaCl and Na2S04 epinephrine and PGEr caused 
maximal inhibition of adenylate cyclase. KCl, C&l 
and RbCl increased enzyme activity less effectively 
than NaCl in the presence of GTP, and these salts like 
LiCl did not allow maximal hormonal inhibition. 
Sucrose (200 mM) was completely ineffective. These 
data suggest that Na’ besides GTP may be specifically 
required for the hormonal inhibitions of adenylate 
cyclase .
4. Discussion 
Guanyl nucleotides and Nd independently of each 
other can reduce binding of agonists to a-adrenergic 
receptors [13,15], very similar as described for opiate 
receptors [12,141. In rabbit platelets, acorrelation 
between the NaCl-induced reduction of agonist-bind- 
ing to cr-adrenergic receptors and their inhibitory 
Table 1 
Influence of various salts of monovalent cations on 
adenylate cyclase inhibition 
Addition Activation Inhibition (%> by 
(-fold) 
Epinephrine PGE, 
None (100 mM) 1.0 0 I3 
NaCI (100 mM) 2.2 21 47 
KCI (100 mM) 1.5 3 25 
CSCI (100 mM) 1.3 0 23 
RbCl (1OOmM) 1.5 9 28 
LM (100 mM) 2.4 7 26 
Na,SQ, ( 50 mM) 1.9 28 62 
Sucrose (200 mM) 1.0 0 18 
In the presence of GTP (10 @I), the effects of the additions 
shown in column 1 were studied on adenylate cyclase activ- 
ity without and with I-epinephrine (100 MM) or PGE, 
(0.1 MM). Column 2 shows activation (-fold) of the enzyme 
relative to control activity, which was 21.2 pmol CAMP . mg 
protein-l. min- ‘. Columns 3 and 4 indicate inhibitions (in 
% of the respective control activities) observed with the 
additions of epinephrine and PGE,, &pectively. Creatine 
phosphate was used as its ammonium salt 
potency on adenylate cyclase has been demonstrated 
[ 151. Similarly to the generaI guanyl nucleotide require- 
ment for hormonal stimulation of adenylate cyclase 
by hormones [5 1, GTP has recently been shown in 
various tissues to be absolutely necessary for the 
inhibition of adenylate cyclase by a-adrenergic [6,10] 
and cholinergic agonists [8,9], by opiates [IO] and 
by adenosine [7]. 
The present data indicate that besides GTP, Na* 
are required for the inhibition of hamster fat cell 
adenylate cyclase by PGEi and the cu-adrenergic 
component of epinephrine. Similar GTP and Na’ 
requirements have been found for a-adrenergic inhi- 
bition of liver adenylate cyclase (K.H.J., R. A. Johnson, 
unpublished observations) and for the in~bition of 
the fat cell and neuroblastoma X glioma hybrid cell 
enzyme by nicotinic acid (K.A., unpublished obser- 
vations) and opiates [22], respectively. 
The data so far available suggest that Na’ besides 
their effects on the hormone binding may also be 
generally involved in the transduction of the inhib- 
itory signal to the adenylate cyclase. Further studies 
on different systems and with isolated components 
of the adenylate cyclase system are required to 
elucidate the exact nature of actions of Nd and 
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guanyl nucleatides in the hormone-induced a enylate 
cyclase inhibition. 
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